Herd immunity is the end game for the pandemic, but the AstraZeneca vaccine wonΓÇÖt get us there

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 February Herd immunity is the end game for the pandemic, but the AstraZeneca vaccine won’t get us there Herd immunity is the end game for the pandemic, but the AstraZeneca vaccine won’t get us there 15/02/2021 | 8 MINS This article by Dr Zoë Hyde from LIT's Medical School originally appeared in The Conversation on 15 February 2021. In the past fortnight, two vaccine stories made headlines around the world. Novavax announced spectacular results for its phase 3 trial, while preliminary data suggest the AstraZeneca vaccine is ineffective against the South African variant. These two vaccines comprise the bulk of Australia’s vaccine portfolio, and the results should prompt an urgent rethink of our vaccination strategy. Australia won’t reach herd immunity with the current plan. Australia’s strategy Australia has secured access to 20 million doses of the Pfizer/BioNTech vaccine, 53.8 million doses of the Oxford/AstraZeneca vaccine, and 51 million doses of the Novavax vaccine. All of these require two doses for maximum effectiveness. The fede

All LIT Search News Topics Latest news Media statements Media contacts Topics Latest news Media statements Media contacts LIT Impact Latest news 2021 February Herd immunity is the end game for the pandemic, but the AstraZeneca vaccine won’t get us there Herd immunity is the end game for the pandemic, but the AstraZeneca vaccine won’t get us there 15/02/2021 | 8 MINS This article by Dr Zoë Hyde from LIT's Medical School originally appeared in The Conversation on 15 February 2021.

In the past fortnight, two vaccine stories made headlines around the world.

We do more when we ask better questions together.